Law360, New York (April 28, 2009, 12:00 AM ET) -- Becton Dickinson & Co. Inc. has reached a $45 million settlement with direct purchaser plaintiffs in five antitrust suits accusing the medical device maker of monopolizing the market for hypodermic products.
The Franklin Lakes, N.J.-based company said in a regulatory filing Tuesday that it would pay the amount into a settlement fund in exchange for being released from all claims brought by the direct purchasers, which includes BD's distributors, in the antitrust action.
The settlement must receive approval from the U.S. District Court for the District...
$45M Settlement Reached In Becton Hypodermic MDL
To view the full article, take a free trial now.
